PREVIOUS ISSUE NEXT ISSUE
November 2016 DT1116_cover.jpg
Melasma data strengthens therapeutic insightAgents that can attack melasma on multiple fronts include retinoids, glucosamine, hydroquinone, topical steroids, phytosterol, glycyrrhetinic acid, niacinamide, soybean extracts, retinoids, salicylic acid and liquirtin, an expert says.
There ought to be a wordMy interest in etymology, (not to be confused with entomology) has grown along with the importance of precise and efficient EMR documentation. Along the way, I learned some great words and acronyms and made up a few of my own.
Informed consent Is evolving: Now what?Dr. Surgery undertook a weekend blepharoplasty course at a well-respected, nationally recognized occuloplastic surgery program. He has since performed three procedures. Dr. Surgery covered the risks with his patients and received both oral and written consent. His third patient unfortunately suffers the rare complication of retrobulbar hematoma and blindness and sues. Should he be concerned?
Appreciating the role of microbial communities on the skinMicrobial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut.
Syphilis cases climbSyphilis has made a resurgence in the U.S., with the number of new cases increasing annually for the last 15 years. New screening recommendations identify patient populations that require at least annual screenings. An expert shares what all this means for dermatologists.
Trends in tickborne diseasesTickborne diseases are a significant health problem in the United States with over 40,000 confirmed or probable cases reported as recently as 2014. Almost 80% of these cases consist of Lyme disease, but other diseases, including viral infections, are present and have been increasing in number over the past 20 years. Experts in tickborne diseases share updates about what’s new and what’s changing in the detection and transmission of these diseases.
8 things about formulating productsSkincare product formulating is a natural for dermatologists, but there are several important considerations before starting what can be an expensive, time-consuming process.
Researchers claim global skincare market is growingA report published by U.S. based market research company Grand View Research suggests the global skincare products market will reach $196.67 billion by 2024, up from an estimated $129.21 billion in 2015.
Tackling tough areas with fillersFilling more challenging areas such as the temples, frontalis, tear trough, jawline and chin can help dermatologists and other core aesthetic specialists stand out among providers of injectable treatments, an expert says.
Study: UV filters interfere with sperm functionResearchers report in a new in vitro study published in Endocrinology that 13 of the 29 ultraviolet (UV) filters they looked at interfere with sperm function.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy.
Update on advanced basal cell carcinoma diagnosis and treatmentDespite increased insight on skin cancer risk factors, the incidence continues to rise worldwide. This review article summarizes new treatment options available, which help to redefine and expand the diagnosis of advanced BCC and allow dermatologists to offer more effective therapy to a broader population.
Courteous to the coreManaging referrals successfully requires being honest with patients and equitable with peers, experts say.
Minding your social media mannersTen tips for developing a social media marketing policy that will help you avoid pitfalls and stay relevant while giving your practice a glowing social presence and reputation.
Moves that could rein in out-of-control drug costsThe third in our series on out-of-control drug costs highlights strategies that should work to stabilize the costs of medications, so that they’re more affordable for patients.
PREVIOUS ISSUE NEXT ISSUE